January 29, 2018 / 11:26 AM / 4 months ago

BRIEF-Biofrontera Receives Favorable CHMP Assessment For Ameluz In Combination With Daylight Photodynamic Therapy

Jan 29 (Reuters) - BIOFRONTERA AG:

* PTA-ADHOC: BIOFRONTERA AG: BIOFRONTERA RECEIVES FAVORABLE CHMP ASSESSMENT FOR AMELUZ® IN COMBINATION WITH DAYLIGHT PHOTODYNAMIC THERAPY

* BASED ON POSITIVE OPINION, CO ANTICIPATES FORMAL APPROVAL BY EUROPEAN COMMISSION IN COMING WEEKS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below